# Xycrobe Therapeutics Inc — Form D

Xycrobe Therapeutics Inc of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-20. The offering totals $1000K, of which $200K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-01-20
- Form: D
- Accession: 0001631127-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1000K
- Amount sold: $200K
- Remaining: $800K
- Investors: 1
- Date of first sale: 2015-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232534

## Issuer

- Name: Xycrobe Therapeutics Inc
- CIK: 0001631127
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3210 MERRYFIELD ROW, SAN DIEGO, CA, 92121
- Phone: (858) 242-1529

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Thomas Hitchcock | Director | San Diego, CA |
| Thomas Hitchcock | Executive Officer | San Diego, CA |

## More

- [CIK 1631127 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1631127&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001631127-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.